Skip to main content
Erschienen in: Infection 4/2023

24.09.2022 | Research

Streptococcal infective endocarditis: clinical features and outcomes according to species

verfasst von: Sandra Chamat-Hedemand, Anders Dahl, Christian Hassager, Magnus Arpi, Lauge Østergaard, Henning Bundgaard, Trine K. Lauridsen, Louise Bruun Oestergaard, Gunnar Gislason, Emil Fosbøl, Niels Eske Bruun

Erschienen in: Infection | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Infective endocarditis (IE) is frequently caused by streptococcal species, yet clinical features and mortality are poorly investigated. Our aim was to examine patients with streptococcal IE to describe clinical features and outcomes according to streptococcal species.

Methods

From 2002 to 2012, we investigated patients with IE admitted to two tertiary Danish heart centres. Adult patients with left-sided streptococcal IE were included. Adjusted multivariable logistic regression analyses were performed, to assess the association between streptococcal species and heart valve surgery or 1-year mortality.

Results

Among 915 patients with IE, 284 (31%) patients with streptococcal IE were included [mean age 63.5 years (SD 14.1), 69% men]. The most frequent species were S. mitis/oralis (21%) and S. gallolyticus (17%). Fever (86%) and heart murmur (81%) were common symptoms, while dyspnoea was observed in 46%. Further, 18% of all cases were complicated by a cardiac abscess/pseudoaneurysm and 25% by an embolic event. Heart valve surgery during admission was performed in 55% of all patients, and S. gallolyticus (OR 0.28 [95% CI 0.11–0.69]) was associated with less surgery compared with S. mitis/oralis. In-hospital mortality was 7% and 1-year mortality 15%, without any difference between species.

Conclusion

S. mitis/oralis and S. gallolyticus were the most frequent streptococcal species causing IE. Further, S. gallolyticus IE was associated with less heart valve surgery during admission compared with S. mitis/oralis IE. Being aware of specific symptoms, clinical findings, and complications related to different streptococcal species, may help the clinicians in expecting different outcomes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Østergaard L, Oestergaard LB, Lauridsen TK, Dahl A, Chaudry M, Gislason G, et al. Long-term causes of death in patients with infective endocarditis who undergo medical therapy only or surgical treatment: a nationwide population-based study. Eur J Cardiothorac Surg. 2018;54:860–6.CrossRefPubMed Østergaard L, Oestergaard LB, Lauridsen TK, Dahl A, Chaudry M, Gislason G, et al. Long-term causes of death in patients with infective endocarditis who undergo medical therapy only or surgical treatment: a nationwide population-based study. Eur J Cardiothorac Surg. 2018;54:860–6.CrossRefPubMed
2.
Zurück zum Zitat Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F, et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7:27–35.CrossRefPubMedPubMedCentral Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F, et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7:27–35.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.CrossRefPubMedPubMedCentral Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–9.CrossRefPubMed Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–9.CrossRefPubMed
5.
Zurück zum Zitat Sunder S, Grammatico-Guillon L, Lemaignen A, Lacasse M, Gaborit C, Boutoille D, et al. Incidence, characteristics, and mortality of infective endocarditis in France in 2011. PLoS ONE. 2019;14: e0223857.CrossRefPubMedPubMedCentral Sunder S, Grammatico-Guillon L, Lemaignen A, Lacasse M, Gaborit C, Boutoille D, et al. Incidence, characteristics, and mortality of infective endocarditis in France in 2011. PLoS ONE. 2019;14: e0223857.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070–6.CrossRefPubMed Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070–6.CrossRefPubMed
7.
Zurück zum Zitat Erdem H, Puca E, Ruch Y, Santos L, Ghanem-Zoubi N, Argemi X, et al. Portraying infective endocarditis: results of multinational ID-IRI study. Eur J Clin Microbiol Infect Dis. 2019;38:1753–63.CrossRefPubMed Erdem H, Puca E, Ruch Y, Santos L, Ghanem-Zoubi N, Argemi X, et al. Portraying infective endocarditis: results of multinational ID-IRI study. Eur J Clin Microbiol Infect Dis. 2019;38:1753–63.CrossRefPubMed
8.
Zurück zum Zitat Østergaard L, Bruun NE, Voldstedlund M, Arpi M, Andersen CØ, Schønheyder HC, et al. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J. 2019;40:3237–44.CrossRefPubMed Østergaard L, Bruun NE, Voldstedlund M, Arpi M, Andersen CØ, Schønheyder HC, et al. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J. 2019;40:3237–44.CrossRefPubMed
9.
Zurück zum Zitat Chamat-Hedemand S, Dahl A, Østergaard L, Arpi M, Fosbøl E, Boel J, et al. Prevalence of infective endocarditis in streptococcal bloodstream infections is dependent on streptococcal species. Circulation. 2020;142:720–30.CrossRefPubMed Chamat-Hedemand S, Dahl A, Østergaard L, Arpi M, Fosbøl E, Boel J, et al. Prevalence of infective endocarditis in streptococcal bloodstream infections is dependent on streptococcal species. Circulation. 2020;142:720–30.CrossRefPubMed
10.
Zurück zum Zitat Nilson B, Olaison L, Rasmussen M. Clinical presentation of infective endocarditis caused by different groups of non-beta haemolytic streptococci. Eur J Clin Microbiol Infect Dis. 2016;35:215–8.CrossRefPubMed Nilson B, Olaison L, Rasmussen M. Clinical presentation of infective endocarditis caused by different groups of non-beta haemolytic streptococci. Eur J Clin Microbiol Infect Dis. 2016;35:215–8.CrossRefPubMed
11.
Zurück zum Zitat Kim SL, Gordon SM, Shrestha NK. Distribution of streptococcal groups causing infective endocarditis: a descriptive study. Diagn Microbiol Infect Dis. 2018;91:269–72.CrossRefPubMed Kim SL, Gordon SM, Shrestha NK. Distribution of streptococcal groups causing infective endocarditis: a descriptive study. Diagn Microbiol Infect Dis. 2018;91:269–72.CrossRefPubMed
12.
Zurück zum Zitat Hoshino T, Fujiwara T, Kilian M. Use of phylogenetic and phenotypic analyses to identify nonhemolytic streptococci isolated from bacteremic patients. J Clin Microbiol. 2005;43:6073–85.CrossRefPubMedPubMedCentral Hoshino T, Fujiwara T, Kilian M. Use of phylogenetic and phenotypic analyses to identify nonhemolytic streptococci isolated from bacteremic patients. J Clin Microbiol. 2005;43:6073–85.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ruch Y, Hansmann Y, Riegel P, Lefebvre N, Mazzucotelli J-P, Douiri N, et al. Virulence of beta-hemolytic streptococci in infective endocarditis. Infection. 2020;48:91–7.CrossRefPubMed Ruch Y, Hansmann Y, Riegel P, Lefebvre N, Mazzucotelli J-P, Douiri N, et al. Virulence of beta-hemolytic streptococci in infective endocarditis. Infection. 2020;48:91–7.CrossRefPubMed
15.
Zurück zum Zitat Lother SA, Jassal DS, Lagacé-Wiens P, Keynan Y. Emerging group C and group G streptococcal endocarditis: a Canadian perspective. Int J Infect Dis. 2017;65:128–32.CrossRefPubMed Lother SA, Jassal DS, Lagacé-Wiens P, Keynan Y. Emerging group C and group G streptococcal endocarditis: a Canadian perspective. Int J Infect Dis. 2017;65:128–32.CrossRefPubMed
16.
Zurück zum Zitat Ivanova-Georgieva R, Ruiz-Morales J, García-Cabrera E, García-López MV, Gálvez-Acebal J, Plata-Ciezar A, et al. Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious. Eur J Clin Microbiol Infect Dis. 2019;38:265–75.CrossRefPubMed Ivanova-Georgieva R, Ruiz-Morales J, García-Cabrera E, García-López MV, Gálvez-Acebal J, Plata-Ciezar A, et al. Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious. Eur J Clin Microbiol Infect Dis. 2019;38:265–75.CrossRefPubMed
17.
Zurück zum Zitat Damlin A, Westling K, Maret E, Stålsby Lundborg C, Caidahl K, Eriksson MJ. Associations between echocardiographic manifestations and bacterial species in patients with infective endocarditis: a cohort study. BMC Infect Dis. 2019;19:1052.CrossRefPubMedPubMedCentral Damlin A, Westling K, Maret E, Stålsby Lundborg C, Caidahl K, Eriksson MJ. Associations between echocardiographic manifestations and bacterial species in patients with infective endocarditis: a cohort study. BMC Infect Dis. 2019;19:1052.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat El Rafei A, DeSimone DC, DeSimone CV, Lahr BD, Steckelberg JM, Sohail MR, et al. Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes. Infect Dis. 2016;48:373–8.CrossRef El Rafei A, DeSimone DC, DeSimone CV, Lahr BD, Steckelberg JM, Sohail MR, et al. Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes. Infect Dis. 2016;48:373–8.CrossRef
19.
Zurück zum Zitat Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, et al. Enterococcus faecalis infective endocarditis. Circulation. 2013;127:1810–7.CrossRefPubMed Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, et al. Enterococcus faecalis infective endocarditis. Circulation. 2013;127:1810–7.CrossRefPubMed
20.
Zurück zum Zitat Buchholtz K, Larsen CT, Hassager C, Bruun NE. Severity of gentamicin’s nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. Clin Infect Dis. 2009;48:65–71.CrossRefPubMed Buchholtz K, Larsen CT, Hassager C, Bruun NE. Severity of gentamicin’s nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. Clin Infect Dis. 2009;48:65–71.CrossRefPubMed
21.
Zurück zum Zitat Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefPubMed Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefPubMed
22.
Zurück zum Zitat Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010;48:1549–54.CrossRefPubMedPubMedCentral Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010;48:1549–54.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Sunnerhagen T, Törnell A, Vikbrant M, Nilson B, Rasmussen M. HANDOC: a handy score to determine the need for echocardiography in non-β-hemolytic streptococcal bacteremia. Clin Infect Dis. 2018;66:693–8.CrossRefPubMed Sunnerhagen T, Törnell A, Vikbrant M, Nilson B, Rasmussen M. HANDOC: a handy score to determine the need for echocardiography in non-β-hemolytic streptococcal bacteremia. Clin Infect Dis. 2018;66:693–8.CrossRefPubMed
25.
Zurück zum Zitat Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Risk factors for pneumococcal endocarditis. Eur J Clin Microbiol Infect Dis. 2018;37:277–80.CrossRefPubMed Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Risk factors for pneumococcal endocarditis. Eur J Clin Microbiol Infect Dis. 2018;37:277–80.CrossRefPubMed
26.
Zurück zum Zitat de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, et al. Characteristics and outcome of streptococcus pneumoniae endocarditis in the XXI Century: a systematic review of 111 cases (2000–2013). Medicine (Baltimore). 2015;94: e1562.CrossRefPubMed de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, et al. Characteristics and outcome of streptococcus pneumoniae endocarditis in the XXI Century: a systematic review of 111 cases (2000–2013). Medicine (Baltimore). 2015;94: e1562.CrossRefPubMed
27.
Zurück zum Zitat Jung C-J, Yeh C-Y, Shun C-T, Hsu R-B, Cheng H-W, Lin C-S, et al. Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve. J Infect Dis. 2012;205:1066–75.CrossRefPubMed Jung C-J, Yeh C-Y, Shun C-T, Hsu R-B, Cheng H-W, Lin C-S, et al. Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve. J Infect Dis. 2012;205:1066–75.CrossRefPubMed
28.
Zurück zum Zitat Schulz C, von Beckerath O, Okrojek R, von Beckerath N, Massberg S. Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin. Thromb J. 2010;8:13.CrossRefPubMedPubMedCentral Schulz C, von Beckerath O, Okrojek R, von Beckerath N, Massberg S. Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin. Thromb J. 2010;8:13.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Pergola V, Salvo GD, Habib G, Avierinos J-F, Philip E, Vailloud J-M, et al. Comparison of clinical and echocardiographic characteristics of streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol. 2001;88:871–5.CrossRefPubMed Pergola V, Salvo GD, Habib G, Avierinos J-F, Philip E, Vailloud J-M, et al. Comparison of clinical and echocardiographic characteristics of streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol. 2001;88:871–5.CrossRefPubMed
30.
Zurück zum Zitat Fernández Hidalgo N, Gharamti AA, Aznar ML, Almirante B, Yasmin M, Fortes CQ, et al. Beta-hemolytic streptococcal infective endocarditis: characteristics and outcomes from a large multinational cohort. Open Forum Infect Dis. 2020;7:120.CrossRef Fernández Hidalgo N, Gharamti AA, Aznar ML, Almirante B, Yasmin M, Fortes CQ, et al. Beta-hemolytic streptococcal infective endocarditis: characteristics and outcomes from a large multinational cohort. Open Forum Infect Dis. 2020;7:120.CrossRef
31.
Zurück zum Zitat Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefPubMed
Metadaten
Titel
Streptococcal infective endocarditis: clinical features and outcomes according to species
verfasst von
Sandra Chamat-Hedemand
Anders Dahl
Christian Hassager
Magnus Arpi
Lauge Østergaard
Henning Bundgaard
Trine K. Lauridsen
Louise Bruun Oestergaard
Gunnar Gislason
Emil Fosbøl
Niels Eske Bruun
Publikationsdatum
24.09.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2023
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-022-01929-1

Weitere Artikel der Ausgabe 4/2023

Infection 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.